Spliced-Leader RNA as a Dynamic Marker for Monitoring Viable Leishmania Parasites During and After Treatment.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
25 Jul 2024
Historique:
received: 28 12 2023
accepted: 25 04 2024
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 25 7 2024
Statut: ppublish

Résumé

Accurate detection of viable Leishmania parasites is critical for evaluating visceral leishmaniasis (VL) treatment response at an early timepoint. We compared the decay of kinetoplast DNA (kDNA) and spliced-leader RNA (SL-RNA) in vitro, in vivo, and in a VL patient cohort. An optimized combination of blood preservation and nucleic acid extraction improved efficiency for both targets. SL-RNA degraded more rapidly during treatment than kDNA, and correlated better with microscopic examination. SL-RNA quantitative polymerase chain reaction emerges as a superior method for dynamic monitoring of viable Leishmania parasites. It enables individualized treatment monitoring for improved prognoses and has potential as an early surrogate endpoint in clinical trials.

Identifiants

pubmed: 39052713
pii: 7720839
doi: 10.1093/infdis/jiae219
doi:

Substances chimiques

DNA, Kinetoplast 0
RNA, Spliced Leader 0
RNA, Protozoan 0
Antiprotozoal Agents 0
Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

183-187

Subventions

Organisme : University of Antwerp
ID : TT-ZAPBOF 33049
Organisme : Directorate-General Development Cooperation and Humanitarian Aid
Organisme : Institute of Tropical Medicine
Organisme : University of Gondar

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Auteurs

Rik Hendrickx (R)

Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp, Antwerp, Belgium.

Roma Melkamu (R)

Leishmaniasis Research and Treatment Center, University of Gondar Hospital, Gondar.

Dagimawie Tadesse (D)

College of Medicine and Health Sciences, Arba Minch University.

Tedla Teferi (T)

Malaria and Leishmaniasis Research and Treatment Center, Arba Minch General Hospital, Arba Minch, Ethiopia.

Pim-Bart Feijens (PB)

Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp, Antwerp, Belgium.

Margot Vleminckx (M)

Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp, Antwerp, Belgium.

Saskia van Henten (S)

Clinical Sciences Department, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.

Fabiana Alves (F)

Drugs for Neglected Diseases initiative, Geneva, Switzerland.

Tamiru Shibru (T)

College of Medicine and Health Sciences, Arba Minch University.

Johan van Griensven (J)

Clinical Sciences Department, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.

Guy Caljon (G)

Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp, Antwerp, Belgium.

Myrthe Pareyn (M)

Clinical Sciences Department, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH